In this study, we have demonstrated that continued inhibition of the drug transporter P-gp after relatively short exposures to chemotherapeutics in a P-gp overexpressing prostate cancer cell line, limited the efflux of the therapeutics from the cells. This evidence concerns the gene PGP and prostate carcinoma.